arrow
R

Roberto Arriga

takis srl
H指数:18
被引数:1,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity

CD64/CD28/CD3ζ嵌合受体重编程T细胞代谢并促进T细胞持久性和免疫功能,同时触发抗体非依赖性和抗体依赖性细胞毒性。

2025-02-170
OA
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
2024-01-051
OAAI
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
2022-10-143
OAAI
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
2022-01-0145
OAAI
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
2019-10-1238
OAAI